Gaceta Sanitaria (Jan 2020)
Tackling second-hand exposure to tobacco smoke and aerosols of electronic cigarettes: the TackSHS project protocol
- Esteve Fernández,
- María José López,
- Silvano Gallus,
- Sean Semple,
- Luke Clancy,
- Panagiotis Behrakis,
- Ario Ruprecht,
- Giuseppe Gorini,
- Ángel López-Nicolás,
- Cornel Radu-Loghin,
- Joan B. Soriano,
- Esteve Fernández,
- Yolanda Castellano,
- Marcela Fu,
- Montse Ballbè,
- Beladenta Amalia,
- Olena Tigova,
- María José López,
- Xavier Continente,
- Teresa Arechávala,
- Elisabet Henderson,
- Silvano Gallus,
- Alessandra Lugo,
- Xiaoqiu Liu,
- Cristina Bosetti,
- Enrico Davoli,
- Paolo Colombo,
- Sean Semple,
- Rachel O’Donnell,
- Ruaraidh Dobson,
- Luke Clancy,
- Sheila Keogan,
- Shashsa Li,
- Elizabeth Breslin,
- Hannah Byrne,
- Panagiotis Behrakis,
- Anna Tzortzi,
- Constantine Vardavas,
- Vergina Konstantina Vyzikidou,
- Stephanie Teloniatis,
- Gerasimos Bakelas,
- George Mattiampa,
- Roberto Boffi,
- Ario Ruprecht,
- Cinzia De Marco,
- Alessandro Borgini,
- Chiara Veronese,
- Martina Bertoldi,
- Andrea Tittarelli,
- Giuseppe Gorini,
- Giulia Carreras,
- Barbara Cortini,
- Simona Verdi,
- Alessio Lachi,
- Elisabetta Chellini,
- Ángel López Nicolás,
- Marta Trapero-Bertran,
- Daniel Celdrán Guerrero,
- Cornel Radu-Loghin,
- Dominick Nguyen,
- Polina Starchenko,
- Joan B. Soriano,
- Julio Ancochea,
- Tamara Alonso,
- María Teresa Pastor,
- Marta Erro,
- Ana Roca,
- Patricia Pérez
Affiliations
- Esteve Fernández
- Institut Català d’Oncologia (ICO), L’Hospitalet de Llobregat (Barcelona), Spain; Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat (Barcelona), Spain; School of Medicine and Health Sciences, Bellvitge Campus, Universitat de Barcelona, L’Hospitalet de Llobregat (Barcelona), Spain; Corresponding author.
- María José López
- Agència de Salut Pública de Barcelona, Barcelona, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain; Institut d’Investigació Biomèdica Sant Pau (IIB St. Pau), Barcelona, Spain
- Silvano Gallus
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
- Sean Semple
- Institute for Social Marketing, University of Stirling, Stirling, Scotland, UK
- Luke Clancy
- TobaccoFree Research Institute Ireland, Dublin, Ireland
- Panagiotis Behrakis
- George D Behrakis Research Lab, Hellenic Cancer Society, Athens, Greece
- Ario Ruprecht
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Giuseppe Gorini
- Istituto per lo Studio, la Prevenzione e la Rete Oncologica, Florence, Italy
- Ángel López-Nicolás
- Universidad Politécnica de Cartagena, Cartagena, Spain
- Cornel Radu-Loghin
- European Network for Smoking and Tobacco Prevention, Brussels, Belgium
- Joan B. Soriano
- Respiratory Department, Hospital Universitario La Princesa, Madrid, Spain
- Esteve Fernández
- Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Spain
- Yolanda Castellano
- Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Spain
- Marcela Fu
- Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Spain
- Montse Ballbè
- Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Spain
- Beladenta Amalia
- Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Spain
- Olena Tigova
- Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Spain
- María José López
- Public Health Agency of Barcelona (ASPB), Spain
- Xavier Continente
- Public Health Agency of Barcelona (ASPB), Spain
- Teresa Arechávala
- Public Health Agency of Barcelona (ASPB), Spain
- Elisabet Henderson
- Public Health Agency of Barcelona (ASPB), Spain
- Silvano Gallus
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS (IRFMN), Italy
- Alessandra Lugo
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS (IRFMN), Italy
- Xiaoqiu Liu
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS (IRFMN), Italy
- Cristina Bosetti
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS (IRFMN), Italy
- Enrico Davoli
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS (IRFMN), Italy
- Paolo Colombo
- Istituto DOXA, Worldwide Independent Network/Gallup International Association, Italy
- Sean Semple
- University of Stirling (UNISTIR), UK
- Rachel O’Donnell
- University of Stirling (UNISTIR), UK
- Ruaraidh Dobson
- University of Stirling (UNISTIR), UK
- Luke Clancy
- TobaccoFree Research Institute Ireland (TFRI), Ireland
- Sheila Keogan
- TobaccoFree Research Institute Ireland (TFRI), Ireland
- Shashsa Li
- TobaccoFree Research Institute Ireland (TFRI), Ireland
- Elizabeth Breslin
- TobaccoFree Research Institute Ireland (TFRI), Ireland
- Hannah Byrne
- TobaccoFree Research Institute Ireland (TFRI), Ireland
- Panagiotis Behrakis
- Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
- Anna Tzortzi
- Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
- Constantine Vardavas
- Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
- Vergina Konstantina Vyzikidou
- Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
- Stephanie Teloniatis
- Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
- Gerasimos Bakelas
- Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
- George Mattiampa
- Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
- Roberto Boffi
- Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Italy
- Ario Ruprecht
- Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Italy
- Cinzia De Marco
- Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Italy
- Alessandro Borgini
- Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Italy
- Chiara Veronese
- Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Italy
- Martina Bertoldi
- Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Italy
- Andrea Tittarelli
- Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Italy
- Giuseppe Gorini
- Istituto per lo Studio, la Prevenzione, e la Rete Oncologica (ISPRO), Italy
- Giulia Carreras
- Istituto per lo Studio, la Prevenzione, e la Rete Oncologica (ISPRO), Italy
- Barbara Cortini
- Istituto per lo Studio, la Prevenzione, e la Rete Oncologica (ISPRO), Italy
- Simona Verdi
- Istituto per lo Studio, la Prevenzione, e la Rete Oncologica (ISPRO), Italy
- Alessio Lachi
- Istituto per lo Studio, la Prevenzione, e la Rete Oncologica (ISPRO), Italy
- Elisabetta Chellini
- Istituto per lo Studio, la Prevenzione, e la Rete Oncologica (ISPRO), Italy
- Ángel López Nicolás
- Polytechnic University of Cartagena (UPCT), Spain
- Marta Trapero-Bertran
- Polytechnic University of Cartagena (UPCT), Spain
- Daniel Celdrán Guerrero
- Polytechnic University of Cartagena (UPCT), Spain
- Cornel Radu-Loghin
- European Network on Smoking and Tobacco Prevention (ENSP), Belgium
- Dominick Nguyen
- European Network on Smoking and Tobacco Prevention (ENSP), Belgium
- Polina Starchenko
- European Network on Smoking and Tobacco Prevention (ENSP), Belgium
- Joan B. Soriano
- Fundación para la Investigación Biomédica del Hospital Universitario La Princesa (IISP), Spain
- Julio Ancochea
- Fundación para la Investigación Biomédica del Hospital Universitario La Princesa (IISP), Spain
- Tamara Alonso
- Fundación para la Investigación Biomédica del Hospital Universitario La Princesa (IISP), Spain
- María Teresa Pastor
- Fundación para la Investigación Biomédica del Hospital Universitario La Princesa (IISP), Spain
- Marta Erro
- Fundación para la Investigación Biomédica del Hospital Universitario La Princesa (IISP), Spain
- Ana Roca
- Fundación para la Investigación Biomédica del Hospital Universitario La Princesa (IISP), Spain
- Patricia Pérez
- Fundación para la Investigación Biomédica del Hospital Universitario La Princesa (IISP), Spain
- Journal volume & issue
-
Vol. 34,
no. 1
pp. 77 – 82
Abstract
Objective: The TackSHS project aims to comprehensively elucidate the impact that exposure to second-hand smoke (SHS) from cigarettes and second-hand aerosols (SHA) from electronic cigarettes have on the respiratory health of the European population according to socioeconomic characteristics and other determinants. Method: The TackSHS project involves a series of coordinated studies carried out by 11 academic and public health organisations from six European countries. The project will investigate: a) the determinants of SHS and SHA exposure assessed at the individual level (surveys on representative general population samples) and in common environments (environmental sampling in specific settings); b) the overall disease burden, mortality and morbidity attributable to such exposure; and c) its economic impact in terms of direct health care costs. The project will also examine specific acute respiratory health changes in healthy individuals and patients with respiratory diseases exposed to SHS and SHA. In addition, the project will examine the effectiveness of a novel intervention to reduce SHS exposure in households where smoking is permitted. All these studies are inter-related and involve collaborative coordination among the participant organisations. Conclusion: The comprehensive, integrated approach of the TackSHS project will enable a significant step forward from the current status quo in the understanding of the impact of SHS and SHA exposure on health and provide the basis for health policy recommendations to help European countries to further reduce the harm caused by SHS and SHA exposure. Resumen: Objetivo: El proyecto TackSHS pretende caracterizar el impacto global de la exposición al humo ambiental de tabaco (HAT) y al aerosol de los cigarrillos electrónicos (ACE) en la salud respiratoria de la población europea según variables socioeconómicas y otros determinantes. Método: El proyecto TackSHS consiste en una serie de estudios coordinados y gestionados por 11 organizaciones académicas y de salud pública de seis países europeos. El proyecto estudiará: a) los determinantes de la exposición al HAT y al ACE a nivel individual (encuestas en muestras representativas de la población general) y en espacios comunes (muestras ambientales en lugares específicos); b) su carga general de enfermedad y la morbimortalidad atribuible a tal exposición; y c) su impacto económico en términos de costes sanitarios directos e indirectos. Además, el proyecto investigará cambios específicos a corto plazo en la salud respiratoria en personas sanas y en pacientes con enfermedades respiratorias expuestos al HAT y al ACE. También examinará la efectividad de una intervención novedosa para reducir la exposición al HAT en hogares donde se permite fumar. Todos estos estudios están interrelacionados y conllevan una coordinación colaborativa entre las instituciones participantes. Conclusión: El enfoque integral del proyecto TackSHS permitirá un avance significativo en la evidencia sobre la comprensión del impacto de la exposición al HAT y al ACE en la salud, y proporcionará una base para desarrollar recomendaciones políticas sanitarias para ayudar a los países europeos a reducir los daños causados por la exposición al HAT y al ACE. Keywords: Second-hand smoke, Passive smoking, Electronic cigarette, Electronic nicotine delivery systems, Aerosols, Second-hand aerosols, Respiratory health, Burden of disease, Economic impact, Palabras clave: Humo ambiental del tabaco, Tabaquismo pasivo, Cigarrillos electrónicos, Sistemas electrónicos de administración de nicotina, Exposición al aerosol, Salud respiratoria, Carga de enfermedad, Impacto económico